Arrowhead Pharmaceuticals, Inc. today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLOtm (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct ...
Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback